Though bisabolol doesnt meet FDA requirements for compounding for 503a pharmacies, it is present in some cream bases already as an excipient, such as Cleoderm
While not a primary indication, many patients notice improvements in skin texture and reduced appearance of fine lines as a secondary benefit of Sermorelin therapy
This approach maximizes weight loss success after Ozempic and when on Mounjaro
Retatrutide is currently in Phase 3 trials and is expected to seek regulatory approval between 2026 and 2027
Luo C, Yu XM, Zeng MQ, Duan CZ, Xu SY, Zhu CY, Zheng ZG, Sun D, Fang J, He DJ (2025) Breaking the diabetes-depression cycle: Exploring shared mechanisms, neuroinflammation, and emerging interventions for metabolic-mood comorbidities
Cancers 16:3671